- call +1-201-465-4211
- email sales@mrinsights.biz
Thalassemia is a general term for a group of inheritable blood disorders, in which the body produces abnormal hemoglobin, resulting in destruction of red blood cells. This ultimately leads to anemia. There are two main types of thalassemia: alpha-thalassemia and beta-thalassemia, the latter being more serious. Beta-thalassemia is a common autosomal recessive disorder worldwide and it is relatively rare in U.S.
Scope of the Report:
The worldwide market for Alpha Thalassemia is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Alpha Thalassemia in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bluebird Bio
Novartis
Kiadis Pharma
Acceleron Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Iron Chelating Drugs
Gene Therapy
Market Segment by Applications, can be divided into
Hospitals
Private clinics
Other
There are 15 Chapters to deeply display the global Alpha Thalassemia market.
Chapter 1, to describe Alpha Thalassemia Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Alpha Thalassemia, with sales, revenue, and price of Alpha Thalassemia, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Alpha Thalassemia, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Alpha Thalassemia market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Alpha Thalassemia sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Alpha Thalassemia Introduction
1.2 Market Analysis by Type
1.2.1 Iron Chelating Drugs
1.2.2 Gene Therapy
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Private clinics
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bluebird Bio
2.1.1 Business Overview
2.1.2 Alpha Thalassemia Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bluebird Bio Alpha Thalassemia Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Alpha Thalassemia Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Alpha Thalassemia Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Kiadis Pharma
2.3.1 Business Overview
2.3.2 Alpha Thalassemia Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Kiadis Pharma Alpha Thalassemia Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Acceleron Pharma
2.4.1 Business Overview
2.4.2 Alpha Thalassemia Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Acceleron Pharma Alpha Thalassemia Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Alpha Thalassemia Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Alpha Thalassemia Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Alpha Thalassemia Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Alpha Thalassemia Manufacturer Market Share in 2017
3.3.2 Top 6 Alpha Thalassemia Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Alpha Thalassemia Market Analysis by Regions
4.1 Global Alpha Thalassemia Sales, Revenue and Market Share by Regions
4.1.1 Global Alpha Thalassemia Sales and Market Share by Regions (2013-2018)
4.1.2 Global Alpha Thalassemia Revenue and Market Share by Regions (2013-2018)
4.2 North America Alpha Thalassemia Sales and Growth Rate (2013-2018)
4.3 Europe Alpha Thalassemia Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Alpha Thalassemia Sales and Growth Rate (2013-2018)
4.5 South America Alpha Thalassemia Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Alpha Thalassemia Sales and Growth Rate (2013-2018)
5 North America Alpha Thalassemia by Countries
5.1 North America Alpha Thalassemia Sales, Revenue and Market Share by Countries
5.1.1 North America Alpha Thalassemia Sales and Market Share by Countries (2013-2018)
5.1.2 North America Alpha Thalassemia Revenue and Market Share by Countries (2013-2018)
5.2 United States Alpha Thalassemia Sales and Growth Rate (2013-2018)
5.3 Canada Alpha Thalassemia Sales and Growth Rate (2013-2018)
5.4 Mexico Alpha Thalassemia Sales and Growth Rate (2013-2018)
6 Europe Alpha Thalassemia by Countries
6.1 Europe Alpha Thalassemia Sales, Revenue and Market Share by Countries
6.1.1 Europe Alpha Thalassemia Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Alpha Thalassemia Revenue and Market Share by Countries (2013-2018)
6.2 Germany Alpha Thalassemia Sales and Growth Rate (2013-2018)
6.3 UK Alpha Thalassemia Sales and Growth Rate (2013-2018)
6.4 France Alpha Thalassemia Sales and Growth Rate (2013-2018)
6.5 Russia Alpha Thalassemia Sales and Growth Rate (2013-2018)
6.6 Italy Alpha Thalassemia Sales and Growth Rate (2013-2018)
7 Asia-Pacific Alpha Thalassemia by Countries
7.1 Asia-Pacific Alpha Thalassemia Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Alpha Thalassemia Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Alpha Thalassemia Revenue and Market Share by Countries (2013-2018)
7.2 China Alpha Thalassemia Sales and Growth Rate (2013-2018)
7.3 Japan Alpha Thalassemia Sales and Growth Rate (2013-2018)
7.4 Korea Alpha Thalassemia Sales and Growth Rate (2013-2018)
7.5 India Alpha Thalassemia Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Alpha Thalassemia Sales and Growth Rate (2013-2018)
8 South America Alpha Thalassemia by Countries
8.1 South America Alpha Thalassemia Sales, Revenue and Market Share by Countries
8.1.1 South America Alpha Thalassemia Sales and Market Share by Countries (2013-2018)
8.1.2 South America Alpha Thalassemia Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Alpha Thalassemia Sales and Growth Rate (2013-2018)
8.3 Argentina Alpha Thalassemia Sales and Growth Rate (2013-2018)
8.4 Colombia Alpha Thalassemia Sales and Growth Rate (2013-2018)
9 Middle East and Africa Alpha Thalassemia by Countries
9.1 Middle East and Africa Alpha Thalassemia Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Alpha Thalassemia Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Alpha Thalassemia Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Alpha Thalassemia Sales and Growth Rate (2013-2018)
9.3 UAE Alpha Thalassemia Sales and Growth Rate (2013-2018)
9.4 Egypt Alpha Thalassemia Sales and Growth Rate (2013-2018)
9.5 Nigeria Alpha Thalassemia Sales and Growth Rate (2013-2018)
9.6 South Africa Alpha Thalassemia Sales and Growth Rate (2013-2018)
10 Global Alpha Thalassemia Market Segment by Type
10.1 Global Alpha Thalassemia Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Alpha Thalassemia Sales and Market Share by Type (2013-2018)
10.1.2 Global Alpha Thalassemia Revenue and Market Share by Type (2013-2018)
10.2 Iron Chelating Drugs Sales Growth and Price
10.2.1 Global Iron Chelating Drugs Sales Growth (2013-2018)
10.2.2 Global Iron Chelating Drugs Price (2013-2018)
10.3 Gene Therapy Sales Growth and Price
10.3.1 Global Gene Therapy Sales Growth (2013-2018)
10.3.2 Global Gene Therapy Price (2013-2018)
11 Global Alpha Thalassemia Market Segment by Application
11.1 Global Alpha Thalassemia Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Private clinics Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Alpha Thalassemia Market Forecast (2018-2023)
12.1 Global Alpha Thalassemia Sales, Revenue and Growth Rate (2018-2023)
12.2 Alpha Thalassemia Market Forecast by Regions (2018-2023)
12.2.1 North America Alpha Thalassemia Market Forecast (2018-2023)
12.2.2 Europe Alpha Thalassemia Market Forecast (2018-2023)
12.2.3 Asia-Pacific Alpha Thalassemia Market Forecast (2018-2023)
12.2.4 South America Alpha Thalassemia Market Forecast (2018-2023)
12.2.5 Middle East and Africa Alpha Thalassemia Market Forecast (2018-2023)
12.3 Alpha Thalassemia Market Forecast by Type (2018-2023)
12.3.1 Global Alpha Thalassemia Sales Forecast by Type (2018-2023)
12.3.2 Global Alpha Thalassemia Market Share Forecast by Type (2018-2023)
12.4 Alpha Thalassemia Market Forecast by Application (2018-2023)
12.4.1 Global Alpha Thalassemia Sales Forecast by Application (2018-2023)
12.4.2 Global Alpha Thalassemia Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Alpha Thalassemia Picture
Table Product Specifications of Alpha Thalassemia
Figure Global Sales Market Share of Alpha Thalassemia by Types in 2017
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
